RICHTER TRANSFORMATION
Clinical trials for RICHTER TRANSFORMATION explained in plain language.
Never miss a new study
Get alerted when new RICHTER TRANSFORMATION trials appear
Sign up with your email to follow new studies for RICHTER TRANSFORMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new drug combo outsmart resistant lymphomas?
Disease control Not yet recruitingThis phase II trial is testing whether a combination of two targeted drugs—pirtobrutinib and sonrotoclax—can shrink tumors in people with three types of B-cell lymphoma: transformed diffuse large B-cell lymphoma, relapsed or refractory chronic lymphocytic leukemia/small lymphocyt…
Matched conditions: RICHTER TRANSFORMATION
Phase: PHASE2 • Sponsor: Changzhou No.2 People's Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New antibody combo targets tough lymphoma in early trial
Disease control Not yet recruitingThis study tests a new drug called EMB-07, which is a bispecific antibody that helps the immune system attack cancer cells. It is for people with aggressive B-cell non-Hodgkin lymphoma, either newly diagnosed or whose cancer has come back. The trial will check safety, side effect…
Matched conditions: RICHTER TRANSFORMATION
Phase: PHASE1, PHASE2 • Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC